| Wang, Jin |
Li2CO3, NCT01669369: Clinical Trial of Lithium Carbonate Combined With Neo-adjuvant Chemotherapy to Treat Osteosarcoma |
|
|
| Recruiting | 4 | 400 | RoW | Lithium Carbonate, Lithobid, Placebo, PLACEBO TREATMENT | Sun Yat-sen University, Qilu Hospital of Shandong University, Nanfang Hospital of Southern Medical University, Shenzhen Second People's Hospital, Guangdong Provincial Hospital of Traditional Chinese Medicine, Shanghai 6th People's Hospital | Osteosarcoma | 12/23 | 12/23 | | |
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) |
|
|
| Active, not recruiting | 4 | 8250 | RoW | Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy | Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases | 04/25 | 04/25 | | |
NCT05561036: A Randomized, Double-blind,Phase Ⅲ Study of Liposome Doxorubicin in Desmoid Tumor |
|
|
| Recruiting | 3 | 72 | RoW | Liposome doxorubicin, liposome adriamycin, Saline Solution | Sun Yat-sen University | Desmoid Tumor | 12/22 | 03/23 | | |
RATIONALE 305, NCT03777657 / 2018-000312-24: Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma |
|
|
| Completed | 3 | 997 | Europe, Japan, US, RoW | Tislelizumab, BGB-A317, Placebo, Cisplatin, Oxaliplatin, Capecitabine, 5-FU | BeiGene | Gastric, or Gastroesophageal Junction Adenocarcinoma | 02/23 | 08/24 | | |
|
|
|
|
NCT04294511: Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of Osteosarcoma |
|
|
| Recruiting | 2 | 75 | RoW | Camrelizumab in Combination With Neoadjuvant Chemotherapy, PD-1 inhibitor | Sun Yat-sen University, Jiangsu HengRui Medicine Co., Ltd. | Osteosarcoma | 03/21 | 09/23 | | |
NCT04606108: Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of High-risk Soft Tissue Sarcoma |
|
|
| Recruiting | 2 | 62 | RoW | Camrelizumab in Combination With Neoadjuvant Chemotherapy, PD-1 inhibitor | Sun Yat-sen University, Jiangsu HengRui Medicine Co., Ltd. | Soft Tissue Sarcoma | 10/21 | 03/24 | | |
Stars, NCT06422858: Sequential Tegafur-gimeracil-oteracil Potassium Capsule (s-1) and Serplulimab Following Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma |
|
|
| Recruiting | 2 | 37 | RoW | Serplulimab, Tegafur-gimeracil-oteracil potassium capsule(S1), Radiotherapy, Cisplatin | Zhejiang Cancer Hospital | Locally Advanced Inoperable Esophageal Squamous Cell Carcinoma | 04/25 | 04/26 | | |
NCT05952128: Phase Ib/II Study of Fluzoparib in Combination With Dalpiciclib in Patients With Locally Advanced or Metastatic Sarcoma |
|
|
| Recruiting | 2 | 50 | RoW | Fluzoparib+ Dalpiciclib | Sun Yat-sen University, Jiangsu Hengrui Pharmaceutical Co., Ltd. | Sarcoma | 12/24 | 12/25 | | |
NCT06718244: Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for MRD-Positive B-ALL Patients in CR1 |
|
|
| Recruiting | 2 | 20 | RoW | single dose of Inaticabtagene autoleucel, Inati-cel, CNCT-19 | Ruijin Hospital | Acute Lymphoblastic Leukemia | 12/29 | 12/29 | | |
| Recruiting | 2 | 170 | RoW | HS-20093 | Hansoh BioMedical R&D Company | Osteosarcoma, Sarcoma | 12/25 | 12/27 | | |
NCT04390737: Evaluate the Safety and Clinical Activity of HH2853 |
|
|
| Recruiting | 1/2 | 254 | US, RoW | HH2853 Tablets | Haihe Biopharma Co., Ltd. | FL Lymphoma, Epithelioid Sarcoma, Peripheral T Cell Lymphoma, Advanced Solid Tumor | 12/25 | 12/25 | | |
NCT05815680: A Study to Evaluate the Drug-drug Interactions (DDIs) of IBI362 With Metformin, Warfarin, Atorvastatin, Digoxin in Overweight or Obese Subjects |
|
|
| Completed | 1 | 48 | RoW | metformin, digoxin, IBI362, warfarin, atorvastatin | Innovent Biologics (Suzhou) Co. Ltd. | Overweight Subjects, Obese Subjects | 08/23 | 10/23 | | |
NCT05793450: Pharmacokinetics of IBI362 in Subjects With and Without Renal Impairment |
|
|
| Completed | 1 | 20 | RoW | IBI362 | Innovent Biologics (Suzhou) Co. Ltd. | Renal Impairment | 09/23 | 11/23 | | |
NCT06416787: Safety and Tolerability of IBI355 in Healthy Volunteers |
|
|
| Active, not recruiting | 1 | 32 | RoW | placebo, IBI355 | Innovent Biologics (Suzhou) Co. Ltd. | Healthy | 02/25 | 12/25 | | |
NCT06110338: Safety and Tolerance Study of IBI355 in Health Volunteers |
|
|
| Completed | 1 | 53 | RoW | placebo, IBI355 | Innovent Biologics (Suzhou) Co. Ltd. | Healthy Subjects | 09/24 | 09/24 | | |
NCT06711991: A Clinical Trial of TQC3927 Powder for Inhalation in Chronic Obstructive Pulmonary Disease |
|
|
| Not yet recruiting | 1 | 48 | RoW | TQC3927 powder for inhalation, TQC3927 powder for inhalation placebo | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Chronic Obstructive Pulmonary Disease | 12/25 | 01/26 | | |
NCT04307030: Study on AI Recognition System Of Heart Sound In Congenital Heart Disease Screening |
|
|
| Recruiting | N/A | 5000 | RoW | Heart Auscultation and Echocardiography | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Congenital Heart Disease in Children | 12/21 | 06/23 | | |
NCT06382532: Diagnosis of Depressive Disorder Malinger Using the Niacin Skin Response Test (NSRT) |
|
|
| Not yet recruiting | N/A | 410 | RoW | Niacin skin reaction test | Air Force Military Medical University, China | Depressive Disorder, Malingering | 05/26 | 05/26 | | |
NCT06662071: A Research Protocol for Evaluating the Efficacy of Perfused Chemotherapeutic Agents for Bladder Cancer Based on Organoid Technology |
|
|
| Recruiting | N/A | 293 | RoW | Organoid culture | Qilu Hospital of Shandong University, The Second Hospital of Shandong University, The First Affiliated Hospital of Shandong First Medical University, Shandong Provincial Hospital, The Third Shandong Provincial Hospital, Taian City Central Hospital, Weifang People's Hospital, Binzhou Medical University, The Affiliated Hospital of Qingdao University, Jining First People's Hospital, Liaocheng People's Hospital, Linyi People's Hospital, Yantai Yuhuangding Hospital, Zibo Central Hospital, Dezhou People's Hospital, The Affiliated Hospital of Jining Medical University and Zaozhuang City, Qilu Hospital of Shandong University (Qingdao) | Bladder Cancer | 09/28 | 09/28 | | |
NCT04802252: A Diagnostic Study of Abnormal Acoustic Waves in Modern Pulse in Benign Prostatic Hyperplasia |
|
|
| Recruiting | N/A | 124 | RoW | | Qianfoshan Hospital | Benign Prostatic Hyperplasia, Radial Artery | 06/22 | 06/22 | | |
